NBK Capital, a private equity firm, completed the acquisition of a majority stake in Polymedic, a pharmaceutical company, from AfricInvest, an investment and financial services company. Financial terms were not disclosed. “This acquisition is very exciting for NBK Capital Partners, as it allows us to grow our presence in a sector that is buoyed by positive developments. Partnering with industry experts such as Dr. Houbachi who carry immense knowledge and experience in the pharmaceutical sector is a great opportunity for us and we look forward to continuing to drive growth through similar successful collaborations to increase our presence in Morocco and North Africa," Yaser Moustafa, NBK Capital Senior Managing Director.